UBS ASSET MANAGEMENT AMERICAS LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,311,230
-38.3%
15,826
+2.3%
0.00%
-50.0%
Q2 2023$3,748,2460.0%15,4720.0%0.00%0.0%
Q1 2023$3,748,246
-99.7%
15,472
-7.0%
0.00%
+100.0%
Q3 2022$1,081,044,000
-9.2%
16,6340.0%0.00%0.0%
Q2 2022$1,190,663,000
-2.4%
16,634
+33.8%
0.00%0.0%
Q1 2022$1,219,631,000
+15.8%
12,4300.0%0.00%
Q4 2021$1,053,317,000
+6.2%
12,4300.0%0.00%
Q3 2021$991,789,000
-18.1%
12,4300.0%0.00%
-100.0%
Q2 2021$1,210,807,000
-12.4%
12,430
+5.1%
0.00%0.0%
Q1 2021$1,382,936,000
+28.2%
11,823
+21.9%
0.00%0.0%
Q4 2020$1,078,460,000
-3.2%
9,701
+3.4%
0.00%0.0%
Q3 2020$1,114,162,000
+14.2%
9,384
+8.9%
0.00%0.0%
Q2 2020$975,650,000
+306.9%
8,615
+139.8%
0.00%
Q1 2020$239,802,000
-62.6%
3,592
-48.9%
0.00%
Q4 2019$641,050,000
+101.4%
7,036
+90.6%
0.00%
Q3 2019$318,324,000
-1.3%
3,692
+20.0%
0.00%
Q2 2019$322,396,000
-16.3%
3,0760.0%0.00%
Q1 2019$385,300,000
+22.1%
3,076
+9.9%
0.00%
Q4 2018$315,616,000
-62.9%
2,800
-29.5%
0.00%
-100.0%
Q3 2018$850,738,000
-34.5%
3,973
-14.5%
0.00%0.0%
Q2 2018$1,299,440,0004,6460.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders